On this page
MLYCD
malonyl-CoA decarboxylase
The MLYCD gene provides instructions for the malonyl-CoA decarboxylase enzyme, which plays a key role in regulating fatty acid metabolism within the body. The MLYCD gene encodes malonyl-CoA decarboxylase, an enzyme central to controlling the balance between fatty acid synthesis and breakdown.
MLYCD is located on the long (q) arm of chromosome 16, at band 16q23.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 16 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MLYCD gene is responsible for producing the malonyl-CoA decarboxylase enzyme, an important component of fatty acid regulation. Fatty acids are critical for numerous biological functions, including providing energy, building cell membranes, and hormone production. This enzyme primarily functions to help manage levels of fatty acids in the body, ensuring they are available when needed and processed effectively.
What the gene does
Malonyl-CoA decarboxylase, encoded by the MLYCD gene, facilitates a specific chemical reaction that converts malonyl-CoA into acetyl-CoA. This conversion is crucial because malonyl-CoA typically inhibits the breakdown of existing fatty acids, while acetyl-CoA is necessary for creating new ones. By converting malonyl-CoA to acetyl-CoA, the enzyme effectively regulates when fatty acids are synthesised and when they are oxidised for energy. Although predominantly found in cardiac muscles, malonyl-CoA decarboxylase is also present in the brain, skeletal muscles, small intestine, liver, pancreas, and kidneys, highlighting its widespread metabolic importance.
Video: Genetics 101
Chromosome location
The MLYCD gene is situated on chromosome 16 at position 16q23.3. This specific location indicates its physical address within the human genome.
Protein structure
The malonyl-CoA decarboxylase protein consists of 493 amino acids. Its structural organisation includes an Alpha-helical domain spanning amino acids 40-190, and a Catalytic domain located from amino acids 191-493, which is critical for its enzymatic activity. Additionally, a Microbody targeting signal is found at amino acids 491-493, directing the protein to its cellular location.
Key variants
Genetic changes, known as variants, within the MLYCD gene can alter the function of the malonyl-CoA decarboxylase enzyme. These variants can range from single nucleotide changes to larger deletions or insertions, potentially affecting the protein's structure, stability, or activity.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.193G>T | p.Glu65Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Deficiency of malonyl-CoA decarboxylase |
c.237_269delinsGTAGA | p.Glu80_Arg90delinsTer | Pathogenic/Likely pathogenic | ★★☆☆ | Deficiency of malonyl-CoA decarboxylase |
c.393_400del | p.Leu133fs | Pathogenic | ★★☆☆ | Deficiency of malonyl-CoA decarboxylase |
c.560C>G | p.Ser187Ter | Pathogenic | ★★☆☆ | MLYCD-related disorder |
c.953_954del | - | Pathogenic | ★★☆☆ | Deficiency of malonyl-CoA decarboxylase |
GRCh37/hg19 16q23.3(chr16:83883746-83971242)x1 | - | Pathogenic | ★☆☆☆ | not specified |
c.1005del | p.Lys336fs | Pathogenic | ★☆☆☆ | Deficiency of malonyl-CoA decarboxylase |
c.172G>T | p.Glu58Ter | Pathogenic | ★☆☆☆ | not provided |
c.247C>T | p.Gln83Ter | Pathogenic | ★☆☆☆ | Deficiency of malonyl-CoA decarboxylase |
c.570_571dup | p.Ser191fs | Pathogenic | ★☆☆☆ | Deficiency of malonyl-CoA decarboxylase |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MLYCD gene are the underlying cause of malonyl-CoA decarboxylase deficiency. This inherited metabolic condition impairs the body's ability to convert fatty acids into energy. Individuals affected by this condition often present with symptoms in infancy or childhood, which can include developmental delay, hypoglycaemia, and a weakened heart muscle.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The MLYCD gene is included in several NHS Genomic Medicine Service national testing panels. It is listed as green on the DDG2P panel, and the Foetal anomalies (R21), Hyperammonaemia, Intellectual disability, Likely inborn error of metabolism (R98), Paediatric or syndromic cardiomyopathy (R135), and Undiagnosed metabolic disorders panels.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the function of the MLYCD gene?
The MLYCD gene provides instructions for producing the malonyl-CoA decarboxylase enzyme, which regulates the balance of fatty acid synthesis and breakdown. This enzyme is crucial for energy production and various cellular functions.
What happens if the MLYCD gene does not function correctly?
Incorrect function of the MLYCD gene, typically due to pathogenic variants, leads to malonyl-CoA decarboxylase deficiency. This condition impairs the body's ability to convert fatty acids into energy, resulting in symptoms such as developmental delay, low blood glucose, and heart issues.
Where is the MLYCD gene found?
The MLYCD gene is located on chromosome 16 at position 16q23.3. The enzyme it produces, malonyl-CoA decarboxylase, is primarily found in heart muscles but also in the brain, skeletal muscles, small intestine, liver, pancreas, and kidneys.
References
- Salomons GS, Jakobs C, Pope LL. Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency. Journal of inherited metabolic disease. 2007. PMID: 17186413
- Wightman PJ, Santer R, Ribes A. MLYCD mutation analysis: evidence for protein mistargeting as a cause of MLYCD deficiency. Human mutation. 2003. PMID: 12955715
- Surendran S, Sacksteder KA, Gould SJ. Malonyl CoA decarboxylase deficiency: C to T transition in intron 2 of the MCD gene. Journal of neuroscience research. 2001. PMID: 11550227